During the past decade, Maternite Regionale Universitaire conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maternite Regionale Universitaire" #1 sponsor was "Central Hospital, Nancy, France" with 13 trials, followed by "Jean Michel Hascoet" with 3 trials sponsored, "Maternite Regionale Universitaire" with 3 trials sponsored, "Institut de Cancérologie de Lorraine" with 1 trials sponsored and "Laboratoire français de Fractionnement et de Biotechnologies" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maternite Regionale Universitaire" #1 collaborator was "ARAIRLOR" with 1 trials as a collaborator, "Central Hospital, Nancy, France" with 1 trials as a collaborator, "Chiesi Farmaceutici S.p.A." with 1 trials as a collaborator, "Maternite Regionale Universitaire" with 1 trials as a collaborator and "Ministere de la Sante et de la Protection Sociale, France" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Maternite Regionale Universitaire" are "Premature Birth" (2 trials), "Premature Infants" (2 trials), "Apnea" (1 trials), "Attention Concentration Difficulty" (1 trials) and "Attention Deficit" (1 trials). Many other conditions were trialed in "Maternite Regionale Universitaire" in a lesser frequency.

Most popular intervention types in "Maternite Regionale Universitaire" are "Other" (9 trials), "Drug" (8 trials), "Diagnostic Test" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Agreement between oral and cervical HPV infection" (1 trials), "Air" (1 trials), "Curosurf" (1 trials) and "Doxapram" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maternite Regionale Universitaire" are 17 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Maternite Regionale Universitaire". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Maternite Regionale Universitaire, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Maternite Regionale Universitaire, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 6 trials that are defined as “Not Applicable".